Immunoadsorption

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Established extracorporeal therapy method, which is carried out with the aid of various adsorbers. For this purpose, the patient's blood is taken into an external blood circuit and separated into blood cells and blood plasma. The blood plasma flows over an adsorber which binds antibodies and immune complexes from the blood plasma. The purified plasma and blood cells are then brought together again and returned to the patient. Each treatment takes several hours. Often it is necessary to replace the absorbed "pathological" immunoglobulins afterwards by intravenous administration of immunoglobulins (IVIG). Immunoadsorption is a treatment alternative and supplement to conventional therapies of various autoimmune diseases. The treatment usually takes 2-3 hours. The frequency of treatment depends on the respective disease and its severity.

IndicationThis section has been translated automatically.

For patients suffering from severe forms of autoimmune diseases involving antibodies and for whom conventional therapies are not sufficiently effective, immunoadsorption (possibly in combination with IVIG) has proven to be an effective therapeutic method. This includes the following clinical pictures:

Authors

Last updated on: 29.10.2020